Free Trial
NASDAQ:MTEX

Mannatech (MTEX) Stock Price, News & Analysis

Mannatech logo
$9.72 +0.22 (+2.26%)
Closing price 05/27/2025 03:50 PM Eastern
Extended Trading
$9.72 +0.01 (+0.05%)
As of 05/27/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mannatech Stock (NASDAQ:MTEX)

Key Stats

Today's Range
$9.52
$9.52
50-Day Range
$7.93
$11.97
52-Week Range
$6.75
$16.49
Volume
238 shs
Average Volume
4,442 shs
Market Capitalization
$18.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

Mannatech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

MTEX MarketRank™: 

Mannatech scored higher than 18% of companies evaluated by MarketBeat, and ranked 851st out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Mannatech.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mannatech is -11.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mannatech is -11.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Mannatech has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Mannatech's valuation and earnings.
  • Percentage of Shares Shorted

    0.78% of the float of Mannatech has been sold short.
  • Short Interest Ratio / Days to Cover

    Mannatech has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mannatech has recently decreased by 17.98%, indicating that investor sentiment is improving significantly.
  • Percentage of Shares Shorted

    0.78% of the float of Mannatech has been sold short.
  • Short Interest Ratio / Days to Cover

    Mannatech has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mannatech has recently decreased by 17.98%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Mannatech has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Mannatech this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mannatech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    41.50% of the stock of Mannatech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 12.98% of the stock of Mannatech is held by institutions.

  • Read more about Mannatech's insider trading history.
Receive MTEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mannatech and its competitors with MarketBeat's FREE daily newsletter.

MTEX Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Mannatech names Robert Toth vice chairman of the board
See More Headlines

MTEX Stock Analysis - Frequently Asked Questions

Mannatech's stock was trading at $13.43 at the start of the year. Since then, MTEX stock has decreased by 27.7% and is now trading at $9.7150.
View the best growth stocks for 2025 here
.

Mannatech, Incorporated (NASDAQ:MTEX) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.80) earnings per share (EPS) for the quarter. The firm earned $26.56 million during the quarter. Mannatech had a negative trailing twelve-month return on equity of 15.62% and a negative net margin of 1.26%.

Shares of MTEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mannatech investors own include CrowdStrike (CRWD), Walt Disney (DIS), Herbalife (HLF), Roku (ROKU), Alibaba Group (BABA), Enphase Energy (ENPH) and Enterprise Products Partners (EPD).

Company Calendar

Last Earnings
5/13/2025
Today
5/27/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MTEX
Employees
250
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.24 million
Pretax Margin
-0.82%

Debt

Sales & Book Value

Annual Sales
$115.04 million
Price / Cash Flow
N/A
Book Value
$5.64 per share
Price / Book
1.72

Miscellaneous

Free Float
1,103,000
Market Cap
$18.47 million
Optionable
Not Optionable
Beta
1.06

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:MTEX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners